Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
33%
Ph early_phase_1
1
11%
Ph phase_3
3
33%
Ph not_applicable
2
22%

Phase Distribution

1

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(4)
Other(2)

Detailed Status

Completed4
Not yet recruiting2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 33 (33.3%)
Phase 43 (33.3%)
N/A2 (22.2%)

Trials by Status

active_not_recruiting111%
not_yet_recruiting222%
completed444%
unknown222%

Recent Activity

1 active trials
Showing 5 of 9
not_yet_recruitingearly_phase_1

Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy

NCT07021430
not_yet_recruitingphase_4

Perennial Malaria Chemoprevention in the Malaria Vaccine Era

NCT07322068
active_not_recruitingnot_applicable

IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding

NCT06870344
completedphase_4

Malaria Therapeutic Efficacy Study (TES) Kenya

NCT04767191
completedphase_3

Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia

NCT04844099
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07021430Early Phase 1

Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy

Not Yet Recruiting
NCT07322068Phase 4

Perennial Malaria Chemoprevention in the Malaria Vaccine Era

Not Yet Recruiting
NCT06870344Not Applicable

IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding

Active Not Recruiting
NCT04767191Phase 4

Malaria Therapeutic Efficacy Study (TES) Kenya

Completed
NCT04844099Phase 3

Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia

Completed
NCT01280162Not Applicable

Malaria Active Epidemiology and Treatment Study

Completed
NCT02974348Phase 3

Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

Completed
NCT01899820Phase 3

Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya

Unknown
NCT01075945Phase 4

Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9